Strategic AI Partners Potential sales opportunity with cloud and AI providers; leverage Dante Genomics collaboration with AWS to position Dante Omics AI as a complementary platform for generative AI in clinical genomics and precision medicine, offering scalable AI-powered analytics to healthcare institutions and researchers.

Rare Disease Focus Opportunities to market Dante Platform for rare disease diagnostics, building on the Rare Disease Health Package launch; target hospitals, clinics, and patient advocacy groups seeking whole genome sequencing plus telemedicine solutions to accelerate diagnosis.

Clinical Precision Sell to clinical care teams and researchers seeking multiomics integration with AI; emphasize the proprietary Dante Platform’s ability to generate actionable insights for clinicians, enabling more precise patient stratification and treatment decisions.

Global Collaboration Explore partnerships with international patient groups and biopharma companies focused on genomics-driven therapies; capitalize on past collaborations (POIC Association) to expand access, sequencing, and data-sharing initiatives in diverse populations.

Growth & Visibility Target mid-size genomics players and biotech CROs with a revenue profile similar to Dante Genomics; offer bundled services (genomics, AI analytics, and telemedicine-enabled care) to broaden market reach and accelerate go-to-market with scalable pricing models.